2m 2m 2m 2m 2m 2m 2m
Intellia Therape (NTLA)
NASDAQ
$12.93+$0.09 (+0.69%)
Price as of Aug 21, 2026 7:56 PM EDT- $1.8BMarket Cap
- 22.05%1-Year Change
- BiotechnologyIndustry
Intellia Therape (NTLA)
$12.93+$0.09 (+0.69%)
NTLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.84 | ||
Change | +$0.40 (+3.22%) | ||
Open | $12.65 | ||
High | $13.13 | ||
Low | $12.65 | ||
Previous Close | $12.44 | ||
Volume | 3,347,693 | ||
30-Day Average Volume | 3,498,878 | ||
1-Week Change | 7.81% | ||
1-Month Change | 11.94% | ||
1-Year Change | 22.05% | ||
3-Year Change | -66.05% | ||
5-Year Change | -91.40% | ||
Fundamentals | |||
Shares Outstanding | 140.1M | ||
Total Assets | $857.2M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $7.7M | ||
Net Income | -$106.6M | ||
Free Cash Flow | -$84.9M | ||
EBIT | -$106.6M | ||
EBITDA | -$104.6M | ||
Net Working Capital | $448.4M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 221 | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | -13 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue